Sparsomycin requirement for inhibiting peptide-bond formation.
D000935:Antifungal Agents / Q000494:pharmacology*; D001665:Binding Sites; D002247:Carbon Isotopes; D002854:Chromatography, Paper; D004151:Dipeptides / Q000096:biosynthesis; D004926:Escherichia coli / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D005672:Fusidic Acid / Q000494:pharmacology; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects; D010445:Peptide Elongation Factors; D010649:Phenylalanine / Q000378:metabolism; D011072:Poly U; D011485:Protein Binding; D014176:Protein Biosynthesis; D011691:Puromycin / Q000494:pharmacology; D012343:RNA, Transfer / Q000378:metabolism; D012156:Reticulocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D012270:Ribosomes / Q000187:drug effects / Q000378:metabolism; D013056:Spectrophotometry, Ultraviolet
D000935:Antifungal Agents; D002247:Carbon Isotopes; D004151:Dipeptides; D010445:Peptide Elongation Factors; D011072:Poly U; D010649:Phenylalanine; D011691:Puromycin; D005672:Fusidic Acid; D012343:RNA, Transfer